New Alliance Capital

New Alliance Capital is a venture capital and private equity firm that specializes in early, growth stage and pre-IPO investments. It primarily invest in high-end manufacturing, technology, advanced agriculture, consumer goods, information, media, energy, recycling, environmental protection, and modern services industry sectors. New Alliance Capital typically invests between $4.71 million and $31.41 million. Qu Liefeng founded it in 2008, with its headquarters in Shanghai in China.

54 past transactions

Guanan Information

Venture Round in 2023
Guanan Information is a technology-driven enterprise that provides big data and pan-security services. It focuses on core directions such as data security, cyberspace security, 5G security, artificial intelligence security, industrial Internet security, and public security. Guanan Information also provides information security solutions for operators, government, finance, electric power, public security, military, medical and other industries.

Yike Polymers

Series B in 2023
Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries.

ATAPEX

Series A in 2022
ATAPEX aims to break the domestic mass production gap of ultra-precision metal sheet processing. Its product business covers Display panel, display terminal, VR/AR display, including Divide Open Mask for AMOLED, Divide Fine Metal Mask, Micro OLED Open Mask for silicon-based OLED, metal support sheet for display terminal and other high-end ultra-fine processing products, connected in series A related industry chain to help customers solve various problems such as less choice of related products, unstable quality, long delivery time etc.

Angstrong Tech

Series B in 2022
Angstrong Tech. is committed to becoming the top enterprise in 3D sensing/smart hardware, for smart phones such as mobile phones, tablets, PCs, security monitoring, financial security, AR/VR, smart retail, safe city, car, AI, robotics, smart home, industrial measurement, medical and many other industries provide a first-class experience in the overall solution, the company is headquartered in Shenzhen, and set up branches in Shanghai and the United States.

Lips Semiconductor

Series A in 2022
Lipps is a research and development, production and sales company of power semiconductor components. It can independently design IGBT/SIC, MOSFET modules and IPM module products, and has established a cooperative relationship with Japanese power module packaging factories.
Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO). With global operations and integrated capabilities, HiRO provides a full range of cross-border solutions and services to its clients, including early pre-clinical strategic planning, clinical trial design, regulatory affairs, pharmacovigilance, statistics, data management, end-to-end project management, and clinical and medical monitoring services. As an emerging global CRO, HiRO strives to become a market-leading, integrated global clinical research organization that works collaboratively with biotech and pharmaceutical companies to bring new products from the laboratory to the market, providing more effective solutions for patients worldwide.

NeuroXess

Angel Round in 2022
NeuroXess is a high-tech life science company focusing on flexible electrode BCI (Brain-computer interface) technologies to protect and explore the brain.

InnoStar Semiconductor

Series A in 2022
InnoStar is a semiconductor storage maker producing storage products in the fields of information security protection, IoT, AI, and cloud.

Yuntu Semiconductor

Series A in 2021
Yuntu Semiconductor is a fabless semiconductor and integrated circuit developer in the field of automotive-grade chips.

LePure Biotech

Series B in 2021
Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples in biosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&D market operation team at home and abroad.

Positive Sequence Biology

Series A in 2021
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

LYNK Pharmaceuticals

Series B in 2021
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.

Petkit

Series D in 2021
Petkit is a technology company that is focused on the development of smart products for pets. It offers an activity monitor that is able to record and analyze pets’ calorie consumption, health, and mood and track their location. Petkit was founded by Weixue Guo and Weike Guo in 2013.

Infervision

Series D in 2021
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers. Beijing Infervision is an artificial intelligence high-tech company committed to applying deep learning technology to assist medical image diagnosis as efficient and accurate solutions. Infravision effectively uses various types of medical data to create clinically valued products and promotes precision analysis in the medical field, especially in assisted image diagnosis. Based on years of research preparation, Infervision launched the world's first "Infervision - artificial intelligence precise healthcare platform", and is the first to release intelligent X-ray assisted diagnosis products and intelligent CT assisted diagnosis products. These products are already in trials at Shanghai Changzheng Hospital, Tongji Medical College of HUST in Wuhan, and Dalian Zhongshan Hospital. The company is also engaged in academic research and has established a deep cooperative relationship with top institutions in Chinese Radiology, combining both medical science and medical technology while laying a solid foundation for artificial intelligence breakthroughs in the medical field. Infervision has established cooperative business partnerships with close to 20 Tertiary Grade A hospitals including Peking Union Medical College Hospital, Shanghai Changzheng Hospital, Tongji Medical College of HUST in Wuhan, and Dalian Zhongshan Hospital, and has successfully broken the barriers between medical data, technology, and application scenarios, creating a unique system of an artificial intelligence computing platform and precise healthcare intelligence system.

Synlight Crystal

Series D in 2021
Synlight Semiconductor is a silicon carbide substrate manufacturing company. They provide stable SiC wafers to downstream customers. It currently manufactures N-type and semi-insulating SiC wafers.

Xinyuan Semiconductor

Seed Round in 2021
Xinyuan Semiconductor focuses on the field of ReRAM.

Tavotek Biotherapeutics

Series A in 2021
Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Our company management and advisors consist of veteran pharmaceutical executives with multiple prior successes in the development of many blockbuster biologics currently in the market. Tavotek has 3 diverse R&D platform for biologics: TavoSelect (an innovative Phage Display Library), TavoPrecise (engineering platform for tissue-specific biologics), and TavoMIP (a multicyclic peptide platform). Along with these platforms, Tavotek has a rich and diverse pipeline of product candidates in various stages of development, focused on cancers, autoimmune conditions, and infectious diseases.

Gensciences

Series A in 2021
Suns Bio Group offers new drug research and development, production, and sales. They offer innovative drugs, strive for high safety, high effectiveness, and a high success rate simultaneously, become a continuous innovator in the global biopharmaceutical field, and benefit patient groups.

Biotheus

Series D in 2021
Biotheus is a biotech company that focuses on curing malignant tumors and autoimmune diseases. Biotheus is committed to the research, development, and commercialization of first-class innovative biologics mainly through the discovery of next-generation multispecific antibodies.

SPH Health Commerce

Series B in 2021
SPH Health Commerce is an Internet hospital and online pharmacy. Based on China's professional pharmacy network, they provide full life-cycle service for novel pharmaceuticals. They also offer professional services such as digital marketing, patient service, innovative payment, Internet hospital operation, and so on.

CapitalBio Technology

Private Equity Round in 2021
CapitalBio Technology is an industry-leading life science company that develops and commercializes total health-care solutions. Their company provides a comprehensive portfolio of top-quality products to a diverse customer base ranging from biomedical researchers to healthcare professionals. Their products include an innovative and broad spectrum of microarray and microfluidic chips and related instruments, software and databases, reagents and consumables for basic and translational research, drug development, clinical diagnostics, biosafety and food safety, and molecular breeding. As a core subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center, CapitalBio Technology was registered in August 2012 and is headquartered in Economic-Technological Development Area in Beijing. CapitalBio Technology is a leading life science company that develops and commercializes total health-care solutions. With more than 35,000 square meters of office space, CapitalBio Technology employs more than 500 employees; 86 percent of these employees have at least Bachelor-level degrees, 14 of which are doctors or post-doctorates.

InnoGrit Corporation

Series B in 2020
InnoGrit, founded by Zining Wu in 2016, is a mid-stage technology company with facilities in San Jose, California, and Shanghai, China. The Company is developing a next-generation data storage processor designed specifically for big data applications in cloud computing, data warehousing, and self-driving vehicle technologies. The InnoGrit processor is expected to improve the speed and efficiency of data transportation and storage, reduce network latency, and eliminate inefficient protocol conversions through the focused combination of storage, networking, and computation functions.

Advaccine

Series B in 2020
Advaccine is a biotech company focused on the discovery of new vaccines, both preventive and therapeutic. We are focused on drugs for unmet clinical needs over the world. All of our products are first-in-class.

ZStack

Series B in 2020
ZStack Cloud Platform has served more than 2,500 enterprise users and established ecological and channel partnerships with more than 250 cloud vendors, covering government, finance, education, internet, energy, manufacturing and many other industries.

Sight Diagnostics

Series D in 2020
Sight Diagnostics is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics. Developed over almost a decade of research, Sight’s technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science. Sight’s first product, Parasight*, has diagnosed malaria in close to 1 million tests across 24 countries. Sight OLO, Sight’s latest FDA 510(k) cleared blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade Complete Blood Count results in minutes. Sight has growing offices in the UK, the US and Israel, and commercial footprint on 5 continents. *Note: Parasight is not available for sale in the US and did not receive FDA clearance for use in the US.

Biotheus

Series B in 2020
Biotheus is a biotech company that focuses on curing malignant tumors and autoimmune diseases. Biotheus is committed to the research, development, and commercialization of first-class innovative biologics mainly through the discovery of next-generation multispecific antibodies.

CapitalBio Technology

Series C in 2020
CapitalBio Technology is an industry-leading life science company that develops and commercializes total health-care solutions. Their company provides a comprehensive portfolio of top-quality products to a diverse customer base ranging from biomedical researchers to healthcare professionals. Their products include an innovative and broad spectrum of microarray and microfluidic chips and related instruments, software and databases, reagents and consumables for basic and translational research, drug development, clinical diagnostics, biosafety and food safety, and molecular breeding. As a core subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center, CapitalBio Technology was registered in August 2012 and is headquartered in Economic-Technological Development Area in Beijing. CapitalBio Technology is a leading life science company that develops and commercializes total health-care solutions. With more than 35,000 square meters of office space, CapitalBio Technology employs more than 500 employees; 86 percent of these employees have at least Bachelor-level degrees, 14 of which are doctors or post-doctorates.

MicroPort Orthopedics

Private Equity Round in 2020
MicroPort Orthopedics is a producer of orthopedic products and a member of the MicroPort Scientific Corporation family of companies. Its knee and hip implants are constantly being improved just as medical procedures. It operates as a start-up of an industry powerhouse. This is critical to achieving its goal of being the growing, innovation-driven company in orthopedics. Their top priority isn’t just to help surgeons get patients back to their feet.

Shanghai Data Exchange

Series A in 2020
Shanghai Data Exchange is a big data circulation and data interconnection service platform. Shanghai Data Exchange's goal is to establish a significant hub node for global data element configuration. Shanghai Data Exchange offers efficient, convenient, compliant, and secure data transaction services for data circulation transactions, while also guiding multiple entities to increase data supply and cultivate and develop a new digital commerce format.

Westwell Lab

Series C in 2020
Westwell Lab is a commercial lab specializing in neuromorphic circuits and systems. Through innovative algorithms, custom silicon, and a biology-inspired approach, the company aims to bring neuromorphic systems to big data, embedded systems, and industry. The company was established in 2015 and is headquartered in Shanghai, China.

QST Corporation

Series B in 2020
Shanghai QST Corporation engages in the design, research and development of MEMS sensors and smart applications for intelligent mobile terminals and IoT applications. The company designs and manufactures high quality sensor products and customizes intelligent applications and services for its clients. Since the company’s foundation in September 2012, it has achieved rapid growth based on the virtual IDM model and using the domestic industrial support system in China. Main products are accelerometers, magnetic sensors, barometers, gyroscopes, light sensors, combined inertial sensors and related intelligent application systems.

Advaccine

Venture Round in 2020
Advaccine is a biotech company focused on the discovery of new vaccines, both preventive and therapeutic. We are focused on drugs for unmet clinical needs over the world. All of our products are first-in-class.

CF PharmTech

Series E in 2020
CF PharmTech was founded in 2007, it is a fully independent, dynamic, integrated, specialty pharmaceutical company focused on the development and manufacturing of products for the treatments of asthma, COPD and allergic rhinitis for the global market. Its mission is to develop high-quality and affordable medicine to help patients achieve effective management care for their respiratory diseases. The headquarters is located in the lakeside of the Caohu District of Suzhou, Jiangsu Province, with many very convenient transportation options available. It only takes thirty minutes by train to Shanghai and four hours by train to Beijing.

Innoviz Technologies

Series C in 2019
Innoviz is a manufacturer of solid-state LiDAR sensors and perception software that enable the mass-production of autonomous vehicles. InnovizPro is a solid-state LiDAR that offers outstanding performance and value for automotive and other applications. InnovizOne is a cutting-edge, automotive-grade LiDAR sensor that provides superior 3D sensing for Level 3-Level 5 autonomous driving. The company is backed by top-tier strategic partners and investors, including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, China Merchants Capital (SINO-BLR Industrial Investment Fund, L.P.), 360 Capital Partners, Glory Ventures, Naver, Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company, and others.

Deepwise

Series C in 2019
Shenzhen Rui Medica is an artificial intelligence technology-based clinical imaging services provider. The company focuses on the development of clinical imaging diagnosis system for early-stage detection of cancer. Its services covers breast cancer, prostate cancer, and chest radiograph.

Innoviz Technologies

Series C in 2019
Innoviz is a manufacturer of solid-state LiDAR sensors and perception software that enable the mass-production of autonomous vehicles. InnovizPro is a solid-state LiDAR that offers outstanding performance and value for automotive and other applications. InnovizOne is a cutting-edge, automotive-grade LiDAR sensor that provides superior 3D sensing for Level 3-Level 5 autonomous driving. The company is backed by top-tier strategic partners and investors, including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, China Merchants Capital (SINO-BLR Industrial Investment Fund, L.P.), 360 Capital Partners, Glory Ventures, Naver, Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company, and others.

Sight Diagnostics

Series C in 2019
Sight Diagnostics is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics. Developed over almost a decade of research, Sight’s technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science. Sight’s first product, Parasight*, has diagnosed malaria in close to 1 million tests across 24 countries. Sight OLO, Sight’s latest FDA 510(k) cleared blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade Complete Blood Count results in minutes. Sight has growing offices in the UK, the US and Israel, and commercial footprint on 5 continents. *Note: Parasight is not available for sale in the US and did not receive FDA clearance for use in the US.

Medical Data System

Series A in 2019
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providing bio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services.

ZStack

Series B in 2018
ZStack Cloud Platform has served more than 2,500 enterprise users and established ecological and channel partnerships with more than 250 cloud vendors, covering government, finance, education, internet, energy, manufacturing and many other industries.

Ping An Good Doctor

Series F in 2018
Ping An Health Internet is a wholly owned subsidiary of China Ping An Group, an important member of the Internet business segment/. It was established in August 2014 with 350 million yuan registered capital and is headquartered in Shanghai, China. Companies around the network of doctors, drug network and information network formed three product lines, involving online inquiry, a plurality of segments of the doctor-patient health care management, drug O2O, electronic health records, chronic disease management, child health services. Chinese company to the mobile Internet era medical wisdom of the leader as the goal, to create a user-stop health management solutions provider, China's largest Internet to build a healthy industry ecosystem. Ping An Health Internet also developed a children's health management and chronic disease management, and other vertical applications, to meet the needs of market segments. Reform the health care system combined with the trend, the company vigorously promote the integration of physician resources.

ShopEx

Series D in 2017
ShopEx is an e-commerce software and service provider in China. It focuses on the research and development of e-commerce software and provision of related solutions and services. ShopEx has become the largest and most experienced professional team and develops e-commerce software with independent core technology and intellectual property rights and services.

Banma Kuaipao

Series C in 2017
Banma Kuaipao develops a mobile application for freight transportation. It also operates mobile applications to book cabs and buses for travelling. Li Jia founded Banman Kuaipao in July 2015. Its headquarters is in Wuhan in China.
Shenzhen Jiedian Technology is a mobile device power bank rental start-up.

eBways.com

Series B in 2017
eBways.com is an online textile form that deals with the selling of dresses. The customer can place an order online and get the products.

CooTek

Series D in 2017
CooTek (NYSE: CTK), founded in 2008, listed on NYSE on September 28th, 2018, is a global and fast-growing mobile internet company that develops innovative mobile apps and artificial intelligence technology. With a massive global user base, CooTek aims to empower users to express themselves and enjoy relevant content seamlessly. CooTek’s flagship mobile app, TouchPal Keyboard, uses unparalleled technology to provide the best input experience to both Android and iPhone users. CooTek has also developed many content-rich apps, spanning across 5 selected verticals including fitness, lifestyle, healthcare, news and short videos, and entertainment. In September 2018, CooTek’s global products reached an average of 213.7 million monthly active users around the world. Headquartered in Shanghai, CooTek offices can be found in Silicon Valley, Beijing, Taipei, Guangzhou, and Shenzhen. Today, CooTek has over 170 patent applications and granted patents worldwide and continually pursue excellence in technology innovation and intellectual property development. CooTek has also established its own big data development center and AI lab in Silicon Valley. Many academic papers written by CooTek have been used in discussions at world-renowned big data and AI conferences such as AAAI, KDD and CIKM.

Sight Diagnostics

Series B in 2016
Sight Diagnostics is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics. Developed over almost a decade of research, Sight’s technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science. Sight’s first product, Parasight*, has diagnosed malaria in close to 1 million tests across 24 countries. Sight OLO, Sight’s latest FDA 510(k) cleared blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade Complete Blood Count results in minutes. Sight has growing offices in the UK, the US and Israel, and commercial footprint on 5 continents. *Note: Parasight is not available for sale in the US and did not receive FDA clearance for use in the US.

SMG Pictures

Venture Round in 2016
SMG Pictures is a film and television content production company.

KanS

Angel Round in 2015
KanS is a cosmetics company that specializes in consumer goods, particularly personal care. It is a scientific anti-aging skin care brand that specializes in Asian skin beauty. It uses scientific research to shape product strength and is committed to providing young consumers with Scientific and professional, precise and efficient skin anti-aging solutions. It is supported by dual scientific research laboratories in China and Japan, as well as a high-quality supply chain system.

Baby Elephant

Angel Round in 2015
Baby Elephant provides baby care, baby skin care, baby bath, detergent, laundry, softener, mosquito repellent, cutlery feeding, pregnancy care, beautiful skin, facial kits, facial masks, cleansing milk, stretch mark massage oil, body care, isolation, sun protection, makeup, antibacterial and anti-mite cleaning series, late cherry revitalizing series, tranexamic acid brightening series, antarctica series, and more products.

Yunnan Jianzhijia Health

Series A in 2014
Jianzhijia adheres to the corporate mission of "establishing credibility with professionalism, high-quality service, and striving to achieve customer satisfaction", adhering to the business positioning of "health + professional + convenience", and practicing "quality assurance, professional service, and customer satisfaction" The service tenet of the company, the implementation of the overall strategy of "group management, diversified operations, and national expansion", relying on the industry's leading operation management technology, efficient logistics system and continuously optimized information system three pillars, starting from Kunming, Based in Yunnan, rooted in the southwest, steadily developing towards the whole country.

YICAI

Series A in 2010
Developer of a financial media company designed for trading market information. The company's products mainly focus on financial information, videos, data reports, in-depth analysis reports, non-stop broadcasts of China and global trading market information, and live broadcasts of major financial events, providing customers with real-time, rigorous, and professional financial news and information services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.